Development of New COSMOS oral RepeatDose and non-cancer Threshold of Toxicological Concern (TTC) Da

来源 :中国毒理学会第七次全国毒理学大会暨第八届湖北科技论坛 | 被引量 : 0次 | 上传用户:RHLOK007
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
  In quantitative risk assessment, the Threshold of Toxicological Concern (TTC) approach provides a method to determine a conservative estimate of a chronic exposure below which there is a very low probability of risk.The TTC concept is a principle, which through a probabilistic approach, establishes human exposure levels for chemicals below which there would be no appreciable risk to human health.TTC is reliant on existing oral toxicity data on a multitude of chemical classes to predict the toxicological potential of non-tested chemicals.The tiered TTC approach has 6 potency tiers covering 4 orders of magnitude (Kroes et al.2004).The upper tiers are based on non-cancer data from a reference database of over 600 chemicals analyzed by Munro et al (1996) and grouped according to the Cramer et al (1978) decision tree according to chemical structure.The utility of TTC has been well established and accepted by regulatory bodies in a number of areas e.g.food packaging migrants, flavor chemicals, genotoxic impurities in pharmaceuticals.In fact, low level constituents or contaminants in a cosmetic product often have insufficient toxicological data to make a full assessment of chronic toxicity.As one of the practical alternatives to repeated dose toxicity testing, the TTC approach is now being expanded to include cosmetics-related chemicals.TTC supports exposure-based safety assessment with a threshold for chemicals below which there is a low probability of a risk to humans.The EU Cosmetics Regulation requires replacement of animal testing of cosmetic products for repeated dose/reproductive toxicity and toxicokinetics.To this end, the COSMOS consortium within SEURAT, a joint cluster between European Commission and Cosmetics Europe, has been engaged in development of computational methods and tools.COSMOS has developed a new toxicity database enriched with oral repeated dose studies for cosmetics-related chemicals.A new Cosmetics Inventory has been defined based on the chemical records from EU COSING database and list from the US Personal Care Products Council.The sources for toxicity data include US Food and Drug Administration, US Environmental Protection Agency, EU Scientific Committee of Consumer Safety, European Chemical Agency, US National Toxicology Program, and literature publications.A new non-cancer TTC database for cosmetics-related chemicals has been compiled by augmenting the COSMOS database with substances from the Munro dataset found in the Cosmetics Inventory.The resulting TTC database contains over 500 chemical structures with oral no-observed-adverse-effect-levels (NOAEL); the toxicity data for the lowest 10th percentile have been further scrutinized in quality control sessions.The inclusion and selection criteria of the NOAEL decisions have been documented transparently.The chemical space of the new TTC database has been compared with other existing TTC databases to demonstrate the coverage suitable for the assessment of cosmetics products.
其他文献
[目的]探讨砷对星形胶质细胞(Astrocyte,AC)内谷胱甘肽(Glutathione,GSH)合成的影响及可能机制.[方法]从新生的Wistar胎大鼠的大脑皮质上提取AC,传代培养3代,以GFAP免疫荧光法鉴定,随机分组,培养液中砷(NaAsO2)含量分别为0 μ mol/L、100 μ mol/L、200 μ mol/L、400 μ mol/L和600 μ mol/L对AC染毒4h,观察细
[目的]研究噻唑烷二酮类药物罗格列酮导致HepaRG细胞氧化损伤的作用特点,探讨其发生的可能机制.[方法]选用HepaRG细胞为体外模型,以12.5、25、50 μ M罗格列酮处理48小时,采用DCFH-DA荧光探针装载,流式细胞仪测定细胞内ROS含量,采用ABTS法检测药物对细胞总抗氧化能力的影响,采用WST法检测超氧物歧化酶活性变化,以及检测过氧化氢酶以及谷胱甘肽过氧化物酶活性的变化.用wes
[目的]研究噻唑烷二酮类药物曲格列酮对HepaRG细胞氧化损伤的作用特点,探讨其发生的可能机制.[方法]选用HepaRG细胞为体外模型,以12.5、25、50μM曲格列酮处理48小时,采用DCFH-DA荧光探针装载,流式细胞仪测定细胞内ROS含量,采用ABTS法检测药物对细胞总抗氧化能力的影响,采用WST法检测超氧物歧化酶活性变化,以及检测过氧化氢酶以及谷胱甘肽过氧化物酶活性的变化.用wester
佐太是珍宝类藏成药中最为核心的成分,是历代藏族名医对剧毒水银,硫磺,能持八金,能持八矿及其他原辅料经特殊工艺炼制而成的一种具有独特疗效的兰黑色粉末制剂.佐太含beta-硫化汞,而常用中药矿物药朱砂则含alpha-硫化汞.汞是已知的环境毒物,而肝脏是其靶器官.佐太和朱砂与氯化汞和甲基汞的肝毒性能相提并论吗?[目的]对佐太,朱砂和汞化合物的肝毒性进行比较,研究佐太朱砂的肝毒性毒性作用,回答含汞传统药物
[目的]通过恒河猴静脉注射重复给予柔红霉素,观察其产生的毒性反应及严重程度、主要毒性靶器官及损害的可逆程度并检测毒代动力学参数,为后续其它试验研究提供依据并为临床合理用药提供一定的参考.[材料和方法]普通级恒河猴28只,3-4岁,雌雄各半,购自中国科学院昆明动物研究所实验动物中心.动物经检疫适应21天后选择24只动物按体重随机分成溶媒对照组,柔红霉素低、中和高剂量组(1.0,2.0,和6.0mg·
[目的]研究转录因子NRF2 (Nuclear factor E2-related factor 2)在人肝细胞癌组织和细胞中的表达、转录活性及在化疗敏感性中的作用;系统评价一组新型NRF2-ARE (Antioxidant Response Element)抑制剂对肝癌细胞中NRF2-ARE活性的影响以及对化疗敏感性的促进效果.[材料和方法]收集临床新鲜肝细胞癌组织及相应癌旁组织标本,进行NRF
[目的]研究抗氧化性丝素蛋白(Silk Fibroin,SF)水解物减弱过氧化氢在人肺癌A549细胞造成的损伤,并研究SF是通过何种途径来减弱损伤的.[材料和方法]用不同浓度50,100,200,400,600,800,1000umol/L H2O2预处理A549细胞24h,测定细胞存活率和脂质过氧化物(MDA),选择适宜浓度的H2O2处理细胞.不加任何药物处理的为空白对照组,实验组分为H2O2预
Clinical evaluation of AGN-203818, an imidazole compound, as an oral agent for the treatment of neuropathic pain was initiated with supportive nonclinical studies showing reversible thyroid follicular
近几年来基于流式细胞术的大鼠体内磷脂酰肌醇聚糖A类(Pig-a)基因突变试验得到了业内同行的广泛关注,并引起国际遗传毒性工作组(IWGT)及美国健康与环境科学研究所(HESI)的重视.2008年启动了大鼠体内Pig-a基因突变试验的国际联合验证,同年HESI的遗传毒理学技术工作小组便成立了Pig-a工作小组,致力于方法学的进一步优化和实验室间联合验证,并探讨成为管理毒理学评价方法的可能性.国家上海
Risk-based prioritizations (RBPs) methodology is developed by US EPA and is qualitative evaluation that indicates whether the US EPA considers a high production volume (HPV) chemical or chemical categ